Acetylcysteine/Ambroxol Hydrochloride

乙酰半胱氨酸/盐酸氨溴索

Report date: 2022/03/14 14:29:21

Base Information

Drug NameAcetylcysteine/Ambroxol Hydrochloride
Drug Alias Name复方乙酰半胱氨酸乙酰半胱氨酸氨溴索注射液阿思欣泰
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals inhibitorsSodium channel alpha subunit modulators
TargetsFree radicalsSodium channel alpha subunit
Therapy Area/IndicationsLiver Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AcetylcysteineAmbroxol Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsLiver Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A